SPY400.09-1.63 -0.41%
DIA322.78+0.55 0.17%
IXIC11,662.79-142.21 -1.20%

AstraZeneca beats quarterly estimates, maintains forecasts

reuters.com · 04/29/2022 02:08
AstraZeneca beats quarterly estimates, maintains forecasts

- Pharma blue chip AstraZeneca AZN on Friday topped analysts' expectations for first-quarter profit and stood by its forecasts for 2022, as newer therapies for cancer, kidney disease and rare conditions made up for a decline in COVID-19 vaccine sales.

Very small blood clot risk after first AstraZeneca COVID shot - UK studies nL4N2UW3BU

FACTBOX-Front runners in development of antibody drugs against COVID-19nL8N2R81NW

UPDATE 2-AstraZeneca COVID drug neutralises Omicron sub-variants in lab studynL3N2VO15V

UPDATE 1-AstraZeneca ready to scrap plans for U.S. approval of COVID shot - FTnL3N2VK3QT

(Reporting by Pushkala Aripaka in Bengaluru and Natalie Grover in London; editing by John Stonestreet)

((Pushkala.A@thomsonreuters.com; Twitter: @pullthekart; Mobile: +91 852 751 3793;))